In situ light dosimetry during photodynamic therapy of Barrett's esophagus with 5‐aminolevulinic acid
- 12 November 2002
- journal article
- clinical trial
- Published by Wiley in Lasers in Surgery and Medicine
- Vol. 31 (5) , 299-304
- https://doi.org/10.1002/lsm.10129
Abstract
Background and Objectives Previous studies with PhotoDynamic Therapy (PDT) in bladder and bronchi have shown that due to scattering and reflection, the actually delivered fluence rate on the surface in a hollow organ can be significantly higher than expected. In this pilot study, we investigated the differences between the primary calculated and the actual measured fluence rate during PDT of Barrett's Esophagus (BE) using 23 independent clinical measurements in 15 patients. Study Design/Materials and Methods A KTP‐dye module laser at 630 nm was used as light source. Light delivery was performed using a cylindrical light diffuser inserted in the center of an inflatable transparent balloon with a length corresponding to the length of the Barrett's epithelium. The total light output power of the cylindrical diffuser was calibrated using an integrating sphere to deliver a primary fluence rate of 100 mW cm−2. Two fiber‐optic pseudo sphere isotropic detectors were placed on the balloon and were used to measure fluence rate at the surface of the esophageal wall during PDT. Results and Conclusions The actual fluence rate measured was 1.5–3.9 times higher than the primary fluence rate for 630 nm. In general, the fluence rate amplification factor decreased with increasing redness of the tissue and was less for shorter diffusers. Fluence rate variations in time were observed which coincided with patients coughing, movement, and esophageal spasms. These factors combined with inter patient variability of the fluence rate measured appears to justify the routine application of this technique in PDT of BE. Lasers Surg. Med. 31:299–304, 2002.Keywords
This publication has 29 references indexed in Scilit:
- Photodynamic therapy for dysplastic Barrett's oesophagus: a prospective, double blind, randomised, placebo controlled trialGut, 2000
- A New Long-Range Through-the-Scope Balloon Applicator for Photodynamic Therapy in the Esophagus and CardiaEndoscopy, 1999
- On the Evolution of Some Endoscopic Light Delivery Systems for Photodynamic TherapyEndoscopy, 1998
- Fluorescence Photobleaching of ALA‐induced Protoporphyrin IX during Photodynamic Therapy of Normal Hairless Mouse Skin: The Effect of Light Dose and Irradiance and the Resulting Biological EffectPhotochemistry and Photobiology, 1998
- Integrating sphere effect in whole-bladder-wall photodynamic therapy: III. Fluence multiplication, optical penetration and light distribution with an eccentric source for human bladder optical propertiesPhysics in Medicine & Biology, 1996
- Construction, quality assurance and calibration of spherical isotropic fibre optic light diffusersLasers in Medical Science, 1995
- Photosensitisation and photodynamic therapy of oesophageal, duodenal, and colorectal tumours using 5 aminolaevulinic acid induced protoporphyrin IX--a pilot study.Gut, 1995
- Photodynamic therapy for esophageal cancer using a 180° windowed esophageal balloonLasers in Surgery and Medicine, 1994
- Comparative study between pulsed and continuous wave lasers for Photofrin® photodynamic therapyLasers in Surgery and Medicine, 1993
- Centering balloon to improve esophageal photodynamic therapyLasers in Surgery and Medicine, 1992